Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa
<p>Dominant mutations in RHO (rhodopsin) are the most common cause of autosomal dominant retinitis pigmentosa (RHO-adRP). RHO-adRP causes progressive loss of rod cells, followed by cone cells, leading to blindness. This disease is a candidate for CRISPR gene editing, as reduction of mutant rho...
Main Author: | Peddle, CF |
---|---|
Other Authors: | MacLaren, RE |
Format: | Thesis |
Language: | English |
Published: |
2021
|
Subjects: |
Similar Items
-
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
by: Saba Shahin, et al.
Published: (2022-04-01) -
Genetic dissection of non-syndromic retinitis pigmentosa
by: Aarti Bhardwaj, et al.
Published: (2022-01-01) -
Visual Acuity by Decade in 139 Males with RPGR-Associated Retinitis Pigmentosa
by: Samantha R. De Silva, DPhil, FRCOphth, et al.
Published: (2024-03-01) -
Clinical and genetic features of Koreans with retinitis pigmentosa associated with mutations in rhodopsin
by: Young Hoon Jung, et al.
Published: (2023-08-01) -
Stem cells set their sights on retinitis pigmentosa
by: Jeannette L Bennicelli, et al.
Published: (2013-08-01)